Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Latent Tuberculosis Infection (LTBI) Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Latent Tuberculosis Infection (LTBI) Testing Overall Market Size
2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size: 2021 VS 2028
2.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Latent Tuberculosis Infection (LTBI) Testing Players in Global Market
3.2 Top Global Latent Tuberculosis Infection (LTBI) Testing Companies Ranked by Revenue
3.3 Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Companies
3.4 Top 3 and Top 5 Latent Tuberculosis Infection (LTBI) Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Latent Tuberculosis Infection (LTBI) Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Latent Tuberculosis Infection (LTBI) Testing Players in Global Market
3.6.1 List of Global Tier 1 Latent Tuberculosis Infection (LTBI) Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Latent Tuberculosis Infection (LTBI) Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Latent Tuberculosis Infection (LTBI) Testing Market Size Markets, 2021 & 2028
4.1.2 Tuberculin Skin Test (TST)
4.1.3 Interferon Gamma Released Assay (IGRA)
4.2 By Type - Global Latent Tuberculosis Infection (LTBI) Testing Revenue & Forecasts
4.2.1 By Type - Global Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2022
4.2.2 By Type - Global Latent Tuberculosis Infection (LTBI) Testing Revenue, 2023-2028
4.2.3 By Type - Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Latent Tuberculosis Infection (LTBI) Testing Market Size, 2021 & 2028
5.1.2 Hospitals and Clinics
5.1.3 Diagnostic Laboratories
5.1.4 Others
5.2 By Application - Global Latent Tuberculosis Infection (LTBI) Testing Revenue & Forecasts
5.2.1 By Application - Global Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2022
5.2.2 By Application - Global Latent Tuberculosis Infection (LTBI) Testing Revenue, 2023-2028
5.2.3 By Application - Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Latent Tuberculosis Infection (LTBI) Testing Market Size, 2021 & 2028
6.2 By Region - Global Latent Tuberculosis Infection (LTBI) Testing Revenue & Forecasts
6.2.1 By Region - Global Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2022
6.2.2 By Region - Global Latent Tuberculosis Infection (LTBI) Testing Revenue, 2023-2028
6.2.3 By Region - Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2028
6.3.2 US Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.3.3 Canada Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.3.4 Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2028
6.4.2 Germany Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4.3 France Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4.4 U.K. Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4.5 Italy Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4.6 Russia Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4.7 Nordic Countries Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4.8 Benelux Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2028
6.5.2 China Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.5.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.5.4 South Korea Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.5.5 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.5.6 India Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2028
6.6.2 Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.6.3 Argentina Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2028
6.7.2 Turkey Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.7.3 Israel Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.7.4 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.7.5 UAE Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
7 Players Profiles
7.1 Qiagen
7.1.1 Qiagen Corporate Summary
7.1.2 Qiagen Business Overview
7.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Major Product Offerings
7.1.4 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue in Global Market (2017-2022)
7.1.5 Qiagen Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Major Product Offerings
7.2.4 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 Oxford Immunotec
7.3.1 Oxford Immunotec Corporate Summary
7.3.2 Oxford Immunotec Business Overview
7.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Major Product Offerings
7.3.4 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue in Global Market (2017-2022)
7.3.5 Oxford Immunotec Key News
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Corporate Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Major Product Offerings
7.4.4 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue in Global Market (2017-2022)
7.4.5 Thermo Fisher Scientific Key News
7.5 Par Sterile
7.5.1 Par Sterile Corporate Summary
7.5.2 Par Sterile Business Overview
7.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Major Product Offerings
7.5.4 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue in Global Market (2017-2022)
7.5.5 Par Sterile Key News
7.6 Bio-Rad Laboratories
7.6.1 Bio-Rad Laboratories Corporate Summary
7.6.2 Bio-Rad Laboratories Business Overview
7.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Major Product Offerings
7.6.4 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue in Global Market (2017-2022)
7.6.5 Bio-Rad Laboratories Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer